Lloviu virus VP24 and VP35 proteins function as innate immune antagonists in human and bat cells

Virology

Volumn 485, Issue , 2015, Pages 145-152

  Feagins, Alicia R ^a   Basler, Christopher F ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Filovirus; Innate immune response; Interferon; Interferon antagonist; Lloviu virus

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; INTERFERON REGULATORY FACTOR 3; KARYOPHERIN ALPHA; KARYOPHERIN ALPHA 5; PROTEIN KINASE R; PROTEIN VP24; PROTEIN VP35; PROTEIN VP40; STAT1 PROTEIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; IRF3 PROTEIN, HUMAN; KARYOPHERIN ALPHA 5, HUMAN; MATRIX PROTEIN; PROTEIN BINDING; STAT1 PROTEIN, HUMAN; VP24 PROTEIN, EBOLA VIRUS; VP35 PROTEIN, FILOVIRUS; VP40 PROTEIN, VIRUS;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FILOVIRUS; GENE EXPRESSION; HUMAN; HUMAN CELL; INHIBITION KINETICS; INNATE IMMUNITY; LLOVIU VIRUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; SENDAI VIRUS; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BAT; BIOSYNTHESIS; CELL LINE; FILOVIRIDAE; GENE EXPRESSION REGULATION; GENETICS; HEK293 CELL LINE; HOST PATHOGEN INTERACTION; IMMUNOLOGY; PATHOGENICITY; PHOSPHORYLATION; SEQUENCE HOMOLOGY; VIROLOGY;

EBOLA VIRUS; LAKE VICTORIA MARBURGVIRUS; MARBURGVIRUS; SENDAI VIRUS;

ALPHA KARYOPHERINS; ANIMALS; CELL LINE; CHIROPTERA; EIF-2 KINASE; FILOVIRIDAE; GENE EXPRESSION REGULATION; HEK293 CELLS; HOST-PATHOGEN INTERACTIONS; HUMANS; IMMUNITY, INNATE; INTERFERON REGULATORY FACTOR-3; INTERFERON-ALPHA; INTERFERON-BETA; PHOSPHORYLATION; PROTEIN BINDING; SENDAI VIRUS; SEQUENCE HOMOLOGY, AMINO ACID; SIGNAL TRANSDUCTION; STAT1 TRANSCRIPTION FACTOR; VIRAL MATRIX PROTEINS; VIRAL PROTEINS; VIRAL REGULATORY AND ACCESSORY PROTEINS;

EID: 84938834605     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2015.07.010     Document Type: Article

References (40)

1. Albarino C.G., Wiggleton Guerrero L., Spengler J.R., Uebelhoer L.S., Chakrabarti A.K., Nichol S.T., Towner J.S. Recombinant Marburg viruses containing mutations in the IID region of VP35 prevent inhibition of Host immune responses. Virology 2015, 476:85-91.
2. Amman B.R., Carroll S.A., Reed Z.D., Sealy T.K., Balinandi S., Swanepoel R., Kemp A., Erickson B.R., Comer J.A., Campbell S., Cannon D.L., Khristova M.L., Atimnedi P., Paddock C.D., Crockett R.J., Flietstra T.D., Warfield K.L., Unfer R., Katongole-Mbidde E., Downing R., Tappero J.W., Zaki S.R., Rollin P.E., Ksiazek T.G., Nichol S.T., Towner J.S. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 2012, 8:e1002877.
3. Bale S., Julien J.P., Bornholdt Z.A., Kimberlin C.R., Halfmann P., Zandonatti M.A., Kunert J., Kroon G.J., Kawaoka Y., MacRae I.J., Wilson I.A., Saphire E.O. Marburg virus VP35 can both fully coat the backbone and cap the ends of dsRNA for interferon antagonism. PLoS Pathog. 2012, 8:e1002916.
4. Bale S., Julien J.P., Bornholdt Z.A., Krois A.S., Wilson I.A., Saphire E.O. Ebolavirus VP35 coats the backbone of double-stranded RNA for interferon antagonism. J. Virol. 2013, 87:10385-10388.
5. Basler C.F., Amarasinghe G.K. Evasion of interferon responses by Ebola and Marburg viruses. J. Interferon Cytokine Res. 2009, 29:511-520.
6. Basler C.F., Mikulasova A., Martinez-Sobrido L., Paragas J., Muhlberger E., Bray M., Klenk H.D., Palese P., Garcia-Sastre A. The Ebola virus VP35 protein inhibits activation of interferon regulatory factor 3. J. Virol. 2003, 77:7945-7956.
7. Basler C.F., Wang X., Muhlberger E., Volchkov V., Paragas J., Klenk H.D., Garcia-Sastre A., Palese P. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc. Natl. Acad. Sci. USA 2000, 97:12289-12294.
8. Cardenas W.B., Loo Y.M., Gale M., Hartman A.L., Kimberlin C.R., Martinez-Sobrido L., Saphire E.O., Basler C.F. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 2006, 80:5168-5178.
9. Feng Z., Cerveny M., Yan Z., He B. The VP35 protein of Ebola virus inhibits the antiviral effect mediated by double-stranded RNA-dependent protein kinase PKR. J. Virol. 2007, 81:182-192.
10. Hartman A.L., Bird B.H., Towner J.S., Antoniadou Z.A., Zaki S.R., Nichol S.T. Inhibition of IRF-3 activation by VP35 is critical for the high level of virulence of ebola virus. J. Virol. 2008, 82:2699-2704.
11. Hartman A.L., Dover J.E., Towner J.S., Nichol S.T. Reverse genetic generation of recombinant Zaire Ebola viruses containing disrupted IRF-3 inhibitory domains results in attenuated virus growth in vitro and higher levels of IRF-3 activation without inhibiting viral transcription or replication. J. Virol. 2006, 80:6430-6440.
12. Hartman A.L., Towner J.S., Nichol S.T. A C-terminal basic amino acid motif of Zaire ebolavirus VP35 is essential for type I interferon antagonism and displays high identity with the RNA-binding domain of another interferon antagonist, the NS1 protein of influenza A virus. Virology 2004, 328:177-184.
13. Harty R.N., Brown M.E., Wang G., Huibregtse J., Hayes F.P. A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding. Proc. Natl. Acad. Sci. USA 2000, 97:13871-13876.
14. Kuhl A., Hoffmann M., Muller M.A., Munster V.J., Gnirss K., Kiene M., Tsegaye T.S., Behrens G., Herrler G., Feldmann H., Drosten C., Pohlmann S. Comparative analysis of Ebola virus glycoprotein interactions with human and bat cells. J. Infect. Dis. 2011, 204(Suppl. 3):S840-S849.
15. Kuhn J.H., Becker S., Ebihara H., Geisbert T.W., Johnson K.M., Kawaoka Y., Lipkin W.I., Negredo A.I., Netesov S.V., Nichol S.T., Palacios G., Peters C.J., Tenorio A., Volchkov V.E., Jahrling P.B. Proposal for a revised taxonomy of the family Filoviridae: classification, names of taxa and viruses, and virus abbreviations. Arch. Virol. 2010, 155:2083-2103.
16. Leroy E.M., Kumulungui B., Pourrut X., Rouquet P., Hassanin A., Yaba P., Delicat A., Paweska J.T., Gonzalez J.P., Swanepoel R. Fruit bats as reservoirs of Ebola virus. Nature 2005, 438:575-576.
17. Leung D.W., Ginder N.D., Fulton D.B., Nix J., Basler C.F., Honzatko R.B., Amarasinghe G.K. Structure of the Ebola VP35 interferon inhibitory domain. Proc. Natl. Acad. Sci. USA 2009, 106:411-416.
18. Leung D.W., Prins K.C., Borek D.M., Farahbakhsh M., Tufariello J.M., Ramanan P., Nix J.C., Helgeson L.A., Otwinowski Z., Honzatko R.B., Basler C.F., Amarasinghe G.K. Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35. Nat. Struct. Mol. Biol. 2010, 17:165-172.
19. Licata J.M., Simpson-Holley M., Wright N.T., Han Z., Paragas J., Harty R.N. Overlapping motifs (PTAP and PPEY) within the Ebola virus VP40 protein function independently as late budding domains: involvement of host proteins TSG101 and VPS-4. J. Virol. 2003, 77:1812-1819.
20. Luthra P., Ramanan P., Mire C.E., Weisend C., Tsuda Y., Yen B., Liu G., Leung D.W., Geisbert T.W., Ebihara H., Amarasinghe G.K., Basler C.F. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 2013, 14:74-84.
21. Maruyama J., Miyamoto H., Kajihara M., Ogawa H., Maeda K., Sakoda Y., Yoshida R., Takada A. Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus. J. Virol. 2014, 88:99-109.
22. Negredo A., Palacios G., Vazquez-Moron S., Gonzalez F., Dopazo H., Molero F., Juste J., Quetglas J., Savji N., de la Cruz Martinez M., Herrera J.E., Pizarro M., Hutchison S.K., Echevarria J.E., Lipkin W.I., Tenorio A. Discovery of an ebolavirus-like filovirus in europe. PLoS Pathog. 2011, 7:e1002304.
23. Ng M., Ndungo E., Jangra R.K., Cai Y., Postnikova E., Radoshitzky S.R., Dye J.M., Ramirez de Arellano E., Negredo A., Palacios G., Kuhn J.H., Chandran K. Cell entry by a novel European filovirus requires host endosomal cysteine proteases and Niemann-Pick C1. Virology 2014, 468-470:637-646.
24. Olival K.J., Hayman D.T. Filoviruses in bats: current knowledge and future directions. Viruses 2014, 6:1759-1788.
25. Pourrut X., Souris M., Towner J.S., Rollin P.E., Nichol S.T., Gonzalez J.P., Leroy E. Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect. Dis. 2009, 9:159.
26. Prins K.C., Cardenas W.B., Basler C.F. Ebola virus protein VP35 impairs the function of interferon regulatory factor-activating kinases IKKepsilon and TBK-1. J. Virol. 2009, 83:3069-3077.
27. Prins K.C., Delpeut S., Leung D.W., Reynard O., Volchkova V.A., Reid S.P., Ramanan P., Cardenas W.B., Amarasinghe G.K., Volchkov V.E., Basler C.F. Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs. J. Virol. 2010, 84:3004-3015.
28. Ramanan P., Edwards M.R., Shabman R.S., Leung D.W., Endlich-Frazier A.C., Borek D.M., Otwinowski Z., Liu G., Huh J., Basler C.F., Amarasinghe G.K. Structural basis for Marburg virus VP35-mediated immune evasion mechanisms. Proc. Natl. Acad. Sci. USA 2012, 109:20661-20666.
29. Reid S.P., Leung L.W., Hartman A.L., Martinez O., Shaw M.L., Carbonnelle C., Volchkov V.E., Nichol S.T., Basler C.F. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 2006, 80:5156-5167.
30. Reid S.P., Valmas C., Martinez O., Sanchez F.M., Basler C.F. Ebola virus VP24 proteins inhibit the interaction of NPI-1 subfamily karyopherin alpha proteins with activated STAT1. J. Virol. 2007, 81:13469-13477.
31. Schumann M., Gantke T., Muhlberger E. Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J. Virol. 2009, 83:8993-8997.
32. Swanepoel R., Smit S.B., Rollin P.E., Formenty P., Leman P.A., Kemp A., Burt F.J., Grobbelaar A.A., Croft J., Bausch D.G., Zeller H., Leirs H., Braack L.E., Libande M.L., Zaki S., Nichol S.T., Ksiazek T.G., Paweska J.T. Studies of reservoir hosts for Marburg virus. Emerg. Infect. Dis. 2007, 13:1847-1851.
33. Timmins J., Schoehn G., Ricard-Blum S., Scianimanico S., Vernet T., Ruigrok R.W., Weissenhorn W. Ebola virus matrix protein VP40 interaction with human cellular factors Tsg101 and Nedd4. J. Mol. Biol. 2003, 326:493-502.
34. Towner J.S., Amman B.R., Sealy T.K., Carroll S.A., Comer J.A., Kemp A., Swanepoel R., Paddock C.D., Balinandi S., Khristova M.L., Formenty P.B., Albarino C.G., Miller D.M., Reed Z.D., Kayiwa J.T., Mills J.N., Cannon D.L., Greer P.W., Byaruhanga E., Farnon E.C., Atimnedi P., Okware S., Katongole-Mbidde E., Downing R., Tappero J.W., Zaki S.R., Ksiazek T.G., Nichol S.T., Rollin P.E. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 2009, 5:e1000536.
35. Urata S., Noda T., Kawaoka Y., Morikawa S., Yokosawa H., Yasuda J. Interaction of Tsg101 with Marburg virus VP40 depends on the PPPY motif, but not the PT/SAP motif as in the case of Ebola virus, and Tsg101 plays a critical role in the budding of Marburg virus-like particles induced by VP40, NP, and GP. J. Virol. 2007, 81:4895-4899.
36. Urata S., Yasuda J. Regulation of Marburg virus (MARV) budding by Nedd4.1: a different WW domain of Nedd4.1 is critical for binding to MARV and Ebola virus VP40. J. Gen. Virol. 2010, 91:228-234.
37. Valmas C., Basler C.F. Marburg virus VP40 antagonizes interferon signaling in a species-specific manner. J. Virol. 2011, 85:4309-4317.
38. Valmas C., Grosch M.N., Schumann M., Olejnik J., Martinez O., Best S.M., Krahling V., Basler C.F., Muhlberger E. Marburg virus evades interferon responses by a mechanism distinct from ebola virus. PLoS Pathog. 2010, 6:e1000721.
39. Xu W., Edwards M.R., Borek D.M., Feagins A.R., Mittal A., Alinger J.B., Berry K.N., Yen B., Hamilton J., Brett T.J., Pappu R.V., Leung D.W., Basler C.F., Amarasinghe G.K. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe 2014, 16:187-200.
40. Yasuda J., Nakao M., Kawaoka Y., Shida H. Nedd4 regulates egress of Ebola virus-like particles from host cells. J. Virol. 2003, 77:9987-9992.